A study published in Nature Microbiology now shows for the first time that Candida auris uses a CO₂-based metabolic strategy to survive in the nutrient-poor conditions of the skin and to better tolerate antifungal therapies – especially amphotericin B (AMB).24. Dezember 2025
News Luna Health raises $23.6M for tiny insulin patch pumpHealthradar20. August 2025 Dive Brief: Luna Health, a startup developing an insulin patch pump to help with overnight glucose control, raised $23.6 million…
